Application of a classifier combining bronchial transcriptomics and chest computed tomography features facilitates the diagnostic evaluation of lung cancer in smokers and nonsmokers.

International Journal of Cancer. Journal International Du Cancer
Yang XiaHuahao Shen

Abstract

Lung cancer screening by computed tomography (CT) reduces mortality but exhibited high false-positive rates. We established a diagnostic classifier combining chest CT features with bronchial transcriptomics. Patients with CT-detected suspected lung cancer were enrolled. The sample collected by bronchial brushing was used for RNA sequencing. The e1071 and pROC packages in R software was applied to build the model. Eventually, a total of 283 patients, including 183 with lung cancer and 100 with benign lesions, were included into final analysis. When incorporating transcriptomic data with radiological characteristics, the advanced model yielded 0.903 AUC with 81.1% NPV. Moreover, the classifier performed well regardless of lesion size, location, stage, histologic type or smoking status. Pathway analysis showed enhanced epithelial differentiation, tumor metastasis, and impaired immunity were predominant in smokers with cancer, whereas tumorigenesis played a central role in nonsmokers with cancer. Apoptosis and oxidative stress contributed critically in metastatic lung cancer; by contrast, immune dysfunction was pivotal in locally advanced lung cancer. Collectively, we devised a minimal-to-noninvasive, efficient diagnostic classifie...Continue Reading

References

Sep 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·R C Thompson, K Ohlsson
Aug 7, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mingzhou GuoMalcolm V Brock
Oct 6, 2007·Chest·M Patricia RiveraUNKNOWN American College of Chest Physicians
Dec 17, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sinéad WeldonClifford C Taggart
Jan 9, 2010·Expert Opinion on Therapeutic Targets·Enzo Lalli, Javier Alonso
Apr 9, 2010·Science Translational Medicine·Adam M GustafsonAvrum Spira
Nov 17, 2010·Pharmacological Reviews·Brice KorkmazFrancis Gauthier
Jul 1, 2011·The New England Journal of Medicine·UNKNOWN National Lung Screening Trial Research TeamJoRean D Sicks
Sep 29, 2011·Journal of Experimental & Clinical Cancer Research : CR·Rebecca S Y Wong
Oct 8, 2011·Chest·Jessica S Wang MemoliGerard A Silvestri
Aug 31, 2012·Frontiers in Immunology·Sumati Rajagopalan, Eric O Long
Jan 5, 2013·Seminars in Cancer Biology·Marjolein van Egmond, Jantine E Bakema
May 23, 2013·The New England Journal of Medicine·Peter D SlyUNKNOWN AREST CF Investigators
Sep 6, 2013·The New England Journal of Medicine·Annette McWilliamsStephen Lam
Dec 24, 2014·British Journal of Cancer·X ZhuangR Bicknell
May 20, 2015·The New England Journal of Medicine·Gerard A SilvestriUNKNOWN AEGIS Study Team
Sep 15, 2015·American Journal of Respiratory and Critical Care Medicine·David E OstUNKNOWN AQuIRE Bronchoscopy Registry
Jan 15, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Peter GoldstrawUNKNOWN International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee Advisory Boards and Particip
May 24, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jennifer BeaneAvrum E Spira
Jun 18, 2017·American Journal of Physiology. Lung Cellular and Molecular Physiology·Laura M López-SánchezAntonio Rodríguez-Ariza
Jun 10, 2018·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Christian RolfoDavid R Gandara
May 3, 2019·The International Journal of Biological Markers·Hui HuangXiang-Yong Li
Jun 23, 2020·Therapeutic Advances in Medical Oncology·Rui JinYang Xia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis